SEC Form 4 · accession 0001144204-15-000242
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Dickey IV
Officer — Chief Financial Officer
Period of report
Dec 31, 2014
Accepted (ET)
Jan 2, 2015 · 9:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | Dec 31, 2014 | A | 484 | $3.2045 | A | 12,066 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares purchased pursuant to NeoStem, Inc.'s 2012 Employee Stock Purchase Plan for the period ended December 31, 2014.